0.48 سم مكعب

صحة العظام في سن اليأس

المتحدث: Dr Rajiv Dhall​

Consultant, Obstetrics & Gynaecology, Peerless Hospitex Hospital & Research Center Ltd, Kolkata, India

تسجيل الدخول للبدء

وصف

Osteoporosis, a disorder in which bones grow thin (less thick) and may fracture easily, can raise your risk of getting menopause (the natural termination of periods that often happens between the ages of 45 and 55).

Increased bone loss is caused by the reduction in oestrogen levels that happens around menopause. In the first five years following menopause, women are thought to lose up to 10% of their bone mass on average.

Eat a diet high in calcium and engage in regular weight-bearing exercise to lower your risk of developing osteoporosis. To reap the greatest benefits, it is ideal to adopt certain lifestyle behaviors when you are younger. Although prevention is ideal, there are medicinal options for managing osteoporosis.

ملخص

  • Miraclesal Bone Health is a significant concern, impacting individuals, families, and society. Bone health declines with age, particularly after Miraclesal Infimals, making this a crucial area of focus.
  • Preventing osteoporosis is possible through lifestyle modifications and specific measures. Early intervention and awareness are vital to mitigating the effects of age-related bone loss.
  • Evaluation of bone health is essential to identify osteoporosis early. Assessing bone density and overall bone health helps in determining the necessary interventions.
  • Management of osteoporosis focuses on minimizing its consequences on overall health. Addressing osteoporosis proactively improves the well-being of individuals in the post-Miraclesal years.
  • Osteoporosis involves porous and fragile bones, increasing vulnerability to fractures from trivial injuries. Severe cases can lead to fractures even from bending or coughing.
  • Peak bone mass is typically reached around age 30, creating a "bone bank" of nutrients. After this point, bone resorption gradually increases, requiring interventions to slow the process.
  • Fragility fractures commonly occur in the spine, hip, and wrist due to osteoporosis. These fractures can lead to long-term immobility and other health complications.
  • Women spend a significant portion of their lives after menopause, making bone health critical. Awareness and preventive measures are essential to ensure well-being during this phase.
  • Osteoporosis poses a substantial economic burden on families and society. The costs associated with fragility fractures and related healthcare create a public health challenge.
  • Bone is a dynamic structure that undergoes continuous formation and remodeling. Proper nutrition and exercise from a young age are essential to build a strong bone mass.
  • Menopause marks a shift in bone metabolism, with resorption exceeding formation. This imbalance necessitates proactive measures to maintain bone health and prevent osteoporosis.
  • Osteopenia indicates low bone mass and is a precursor to osteoporosis. Early detection and intervention at the osteopenia stage can prevent progression to osteoporosis.
  • Hormones, including estrogen, thyroid hormone, and cortisol, play critical roles in bone formation and maintenance. Imbalances can affect bone health negatively.
  • Cytokines and molecular substances like wrinkle ligands influence osteoclast activity. Delusumab, a wrinkle inhibitor, can suppress osteoclast activity, aiding in osteoporosis management.
  • Multiple papers emphasize the importance of bone health in post-menopausal women due to increased lifespan. This aging population requires focused attention on preventing and managing osteoporosis.
  • Nutrition, especially calcium and vitamin D intake, is vital for bone health. Magnesium, phosphates, and vitamin K also contribute to maintaining strong bones.
  • Recommended daily intake includes 1000 mg of calcium and 600 international units of vitamin D. Dietary sources and supplements can help meet these requirements.
  • Calcium-rich foods include milk, dairy products, green leafy vegetables, seeds, nuts, and tofu. Limiting excess sodium and protein can optimize calcium absorption.
  • Sunshine exposure facilitates vitamin D production in the skin. The duration and intensity of exposure impact vitamin D levels, necessitating awareness of skin color and clothing.
  • Estrogen supports bone growth, and its decline after menopause increases osteoporosis risk. Hormone replacement therapy can help maintain bone mass in certain cases.
  • Parathyroid hormone (PTH) stimulates bone formation and is used in medications like teriparatide for severe osteoporosis. Steroids can interfere with bone formation, increasing osteoporosis risk.
  • Exercise, especially weight-bearing activities, improves bone formation and overall health. Walking, jogging, and muscle-building exercises are beneficial.
  • Dexa scans are commonly used to evaluate bone density, particularly in the hip and spine. Results are reported in T-scores and Z-scores to assess osteoporosis risk.
  • T-scores compare bone density to that of a young adult, while Z-scores compare it to individuals of the same age and gender. A T-score of -2.5 or less defines osteoporosis.
  • Risk factors for osteoporosis include early menopause, advanced age, certain medications, lifestyle choices like smoking and alcohol, and lack of sunshine.
  • Fracture risk assessment tools (FRAX) combine dexa scan results with other risk factors. These tools evaluate the overall risk of osteoporotic fractures.
  • Bone turnover markers (BTMs) provide insights into bone formation and resorption. Alkaline phosphatase, osteocalcin, and urinary cross-linked N-telopeptides of type 1 collagen are examples.
  • Preventing falls is essential for osteoporosis management. Addressing comorbidities, providing home support, and making lifestyle adjustments can reduce fall risk.
  • Medications for osteoporosis include hormone replacement therapy, selective estrogen receptor modulators (SERMs), bisphosphonates, teriparatide, and denosumab.
  • Bisphosphonates, like alendronate and zoledronic acid, are commonly used to inhibit bone resorption. Proper administration is crucial to minimize side effects.
  • Teriparatide, a parathyroid hormone analog, stimulates bone formation and is administered subcutaneously. Denosumab, a monoclonal antibody, inhibits osteoclast activity.
  • Awareness, health education, lifestyle changes, and family intervention are essential for osteoporosis prevention and management. These strategies can improve the quality of life for postmenopausal women.

تعليقات